1.Haider H.K., Ashraf M. Bone marrow stem cell transplantation for cardiac repair. AJP-Heart 2005; 288: 2557-67.2.Henning R.J., Burgos J.D., Ondrovic L. et al. Human umbilical cord blood mononuclear cells for the treatment of acute myocardial infarction. Cell Transpl. 2004; 13(7-8): 729-З9.3.Hirata Y., Sata M., Motomura N. et al. Human umbilical cord blood cells improve cardiac function after myocardial infarction. Biochem. Biophys. Res. Commun. 2005; 327: 609-14.4.Kim B.O., Tian H., Prasongsukarn K. et al. Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine model. Circ. 2005; 112(9 Suppl): I96-I104.5.Kogler G., Sensken S., Airey J.A. et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J. Exp. Med. 2004; 2: 123-35.6.Leor J., Guetta E., Feinberg M.S. et al. Human umbilical cord blood derived CD133+ cells enhance function and repair of the infarcted myocardium. Stem Cells 2006; 24: 772-80.7.Liu B., Buckley S.M., Lewis I.D. et al. Homing defect of cultured human hematopoietic cells in the NOD/SCID mouse is mediated by Fas/CD95. Exp. Hematol. 2003; 31: 824-З2.8.Ma N., Stamm C., Kaminski A. et al. Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice. Cardiovasc. Res. 2005; 66(1): 45-54.9.Vasa M., Fichtlscherer S., Aicher A. et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 2001; 89(1): E1-7.